Good afternoon :)
Place Order
Add to Watchlist

Torrent Pharmaceuticals Ltd

TORNTPHARM

Torrent Pharmaceuticals Ltd

TORNTPHARM
Health CarePharmaceuticals
LargecapWith a market cap of ₹1,18,374 cr, stock is ranked 82
Low RiskStock is 1.69x as volatile as Nifty
3,511.050.38% (+13.45)
3,511.050.38% (+13.45)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
LargecapWith a market cap of ₹1,18,374 cr, stock is ranked 82
Low RiskStock is 1.69x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
LargecapWith a market cap of ₹1,18,374 cr, stock is ranked 82
Low RiskStock is 1.69x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
68.2317.270.80%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
52.566.720.47%

Forecast & Ratings

Detailed Forecast 
76%
Analysts have suggested that investors can buy this stock

from 29 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.06%, vs industry avg of 9.03%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 3.52% to 2.88%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 30.58%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue6,912.506,038.996,248.677,729.858,060.618,061.488,704.609,665.2910,874.1311,132.00
Raw Materialssubtract1,725.041,931.392,035.672,136.252,300.052,425.662,368.152,569.002,841.227,515.00
Power & Fuel Costsubtract92.59107.98118.77132.46128.19122.94144.19155.28145.20
Employee Costsubtract842.35993.411,135.251,403.791,429.041,439.621,526.451,677.691,984.40
Selling & Administrative Expensessubtract847.92964.141,084.651,299.491,317.151,155.101,278.571,502.701,674.65
Operating & Other expensessubtract639.63441.50226.241,074.76594.52381.171,244.11873.43714.72
Depreciation/Amortizationsubtract237.55306.92408.60617.69654.38657.79662.16706.59808.27814.00
Interest & Other Itemssubtract183.98205.56308.48503.75450.71352.94255.06333.44353.56326.00
Taxes & Other Itemssubtract610.20154.54252.90125.38161.85274.38448.73601.93695.73742.00
EPS51.2127.5820.0312.8930.2836.9922.9636.7948.9451.26
DPS17.507.007.008.5016.0017.5024.0022.0028.0028.00
Payout ratio0.340.250.350.660.530.471.050.600.570.55

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 25PDF
Jan 25PDF
Oct 26PDF
Jul 27PDF
FY 2023

Annual report

PDF

Investor Presentation

May 30PDF
Jan 25PDF
Oct 21PDF
+2 more
FY 2024

Annual report

PDF

Investor Presentation

Aug 7PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Torrent Pharmaceuticals Ltd71.4717.270.80%
Sun Pharmaceutical Industries Ltd47.576.790.71%
Cipla Ltd30.804.740.83%
Dr Reddy's Laboratories Ltd19.753.900.61%

Price Comparison

Compare TORNTPHARM with any stock or ETF
Compare TORNTPHARM with any stock or ETF
TORNTPHARM
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.25%3.69%3.39%14.46%7.21%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep12.84%13.15%14.09%14.14%14.22%14.46%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
Kotak Emerging Equity Fund - Growth - Direct Plan

Growth
0.4535%1.02%-0.29%44/74 (-10)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
0.2528%1.11%-0.05%20/70 (0)
Nippon India Pharma Fund - Growth - Direct Plan

Growth
0.1424%1.95%-0.32%20/36 (-2)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Trend In Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

TORNTPHARM has shown inconsistent dividend trend over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.80%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹8.01 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJun 21, 2024

Final
Final | Div/Share: ₹6.00

Dividend/Share

₹6.00

Ex DateEx Date

Jun 21, 2024

Cash Dividend

Ex DateEx DateFeb 12, 2024

Interim
Interim | Div/Share: ₹22.00

Dividend/Share

₹22.00

Ex DateEx Date

Feb 12, 2024

Cash Dividend

Ex DateEx DateJun 23, 2023

Final
Final | Div/Share: ₹8.00

Dividend/Share

₹8.00

Ex DateEx Date

Jun 23, 2023

Cash Dividend

Ex DateEx DateFeb 3, 2023

Interim
Interim | Div/Share: ₹14.00

Dividend/Share

₹14.00

Ex DateEx Date

Feb 3, 2023

Cash Dividend

Ex DateEx DateJun 3, 2022

Special
Special | Div/Share: ₹15.00

Dividend/Share

₹15.00

Ex DateEx Date

Jun 3, 2022